Genitourinary Cancers
Showing 1 - 25 of 4,957
Gender Related Coping and Survivorship for Genitourinary Cancers
Recruiting
- Bladder Cancer
- Additional Education
- +2 more
-
Washington, District of Columbia
- +1 more
Jan 23, 2023
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
- Thymus Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Reconstitution ofHuman Immune System inPatient Derived Xenograft
Suspended
- Genito Urinary Cancer
- +3 more
- Bone marrow biopsy
- Tumor biopsy
-
Durham, North CarolinaDuke University Medical Center
Nov 17, 2022
Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,
Recruiting
- Endocrine/Neuroendocrine
- +4 more
- Fludarabine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Integrated Molecular Profiling in Advanced Cancers Trial
Active, not recruiting
- Breast Cancer
- +9 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 26, 2022
Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma Trial in New York (Nivolumab, Atezolizumab, Radiation &
Terminated
- Metastatic Renal Cell Carcinoma
- Metastatic Urothelial Carcinoma
- Nivolumab
- +3 more
-
New York, New YorkWeill Cornell Medicine - New York Presbyterian Hospital
Aug 26, 2021
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021
Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy
Recruiting
- Urothelial Cancer
- +4 more
- M7824
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors Trial run by the National
Not yet recruiting
- Adenocarcinoma of the Bladder
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Chemotherapy-Induced Nausea in Genitourinary Cancer and Changes
Not yet recruiting
- Bladder Cancer
- +2 more
- Blood and Tissue
-
Jacksonville, Florida
- +2 more
Apr 6, 2023
Survivorship, Prostate Cancer, Kidney Cancer Trial in Cork (Physiotherapy, Dietitian Support, Nursing and Psychosocial)
Recruiting
- Survivorship
- +5 more
- Physiotherapy
- +2 more
-
Cork, IrelandCork University Hospital
Jul 17, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)
Completed
- Breast Cancer
- +7 more
- IGF-Methotrexate conjugate
-
Chicago, IllinoisUniversity of Illinois at Chicago
Aug 20, 2019
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of
Not yet recruiting
- Bone Metastases
- Urogenital Cancer
- Tc-99m MDP and gamma camera
- (no location specified)
Oct 26, 2022
Cervical Cancer, Uterine Cancer Trial (Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT))
Not yet recruiting
- Cervical Cancer
- Uterine Cancer
- Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
- (no location specified)
Feb 24, 2023
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a
Recruiting
- Prostate Cancer
- +4 more
- Performing cognitive prostate biopsy with a radiologist's guidance with map
- Performing cognitive prostate biopsy without a radiologist's guidance with map
-
Istanbul, TurkeyMarmara University, School of Medicine, Department of Urology
Jun 5, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Other Cancer Trial in Boston (Usual Care, Geriatric Oncology Collaborative Care)
Completed
- Other Cancer
- Usual Care
- Geriatric Oncology Collaborative Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Apr 6, 2022
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Prostate Cancer, Bladder Cancer, Kidney Cancer Trial run by the NCI (Ferumoxytol, Magnetic Resonance Imaging (MRI))
Completed
- Prostate Cancer
- +2 more
- Ferumoxytol
- Magnetic Resonance Imaging (MRI)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 5, 2019
Serum and Tissue Samples From Biopsy-Proved or Suspected
Recruiting
- Malignant Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States
Recruiting
- Bladder Adenocarcinoma
- +45 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +563 more
Aug 24, 2022
Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)
Recruiting
- Prostate Adenocarcinoma
- Integrated boost
-
Valence, Drôme, France
- +3 more
Oct 26, 2022
